UTHR
United Therapeutics CorporationNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$23.17B
P/E Ratio
20.19
EPS
$27.04
Beta
0.57
52W High
$609.35
52W Low
$272.12
50-Day MA
$567.61
200-Day MA
$491.97
Dividend Yield
—
Profit Margin
40.60%
Forward P/E
19.88
PEG Ratio
2.23
About United Therapeutics Corporation
United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.
Fundamentals
| Revenue (TTM) | $3.17B |
| Gross Profit (TTM) | $2.74B |
| EBITDA | $1.55B |
| Operating Margin | 41.70% |
| Return on Equity | 20.30% |
| Return on Assets | 12.60% |
| Revenue/Share (TTM) | $72.12 |
| Book Value | $139.98 |
| Price-to-Book | 3.92 |
| Price-to-Sales (TTM) | 7.31 |
| EV/Revenue | 6.32 |
| EV/EBITDA | 11.69 |
| Quarterly Earnings Growth (YoY) | -12.20% |
| Quarterly Revenue Growth (YoY) | -1.60% |
| Shares Outstanding | $42.45M |
| Float | $38.92M |
| % Insiders | 2.04% |
| % Institutions | 102.11% |
Historical Volatility
HV 10-Day
20.17%
HV 20-Day
17.77%
HV 30-Day
25.82%
HV 60-Day
34.00%
HV Rank
29.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($665.23 target)
3
Strong Buy9
Buy3
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026